Cargando…

Detection of Cancer Mutations by Urine Liquid Biopsy as a Potential Tool in the Clinical Management of Bladder Cancer Patients

SIMPLE SUMMARY: The management of bladder cancer faces multiple challenges concerning the diagnostic and follow-up approaches. The standard diagnostic examination comprises invasive cystoscopy. Urine cytology and recently proposed urine-based biomarkers have been unable to replace cystoscopy, thus p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ibrahim, Nurul Khalida, Eraky, Ahmed, Eggers, Jan, Steiert, Tim Alexander, Sebens, Susanne, Jünemann, Klaus-Peter, Hendricks, Alexander, Bang, Corinna, Stanulla, Martin, Franke, Andre, Hamann, Claudius, Röcken, Christoph, Arnold, Norbert, Hinze, Laura, Forster, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870091/ https://www.ncbi.nlm.nih.gov/pubmed/35205727 http://dx.doi.org/10.3390/cancers14040969

Ejemplares similares

Combining Solid and Liquid Biopsy for Therapy Monitoring in Esophageal Cancer
por: Richter, Florian, et al.
Publicado: (2023)

Rapid response of stage IV colorectal cancer with APC/TP53/KRAS mutations to FOLFIRI and Bevacizumab combination chemotherapy: a case report of use of liquid biopsy
por: Hendricks, Alexander, et al.
Publicado: (2020)

GSK3α Regulates Temporally Dynamic Changes in Ribosomal Proteins upon Amino Acid Starvation in Cancer Cells
por: Loxha, Lorent, et al.
Publicado: (2023)

Biomarkers in Liquid Biopsies for Prediction of Early Liver Metastases in Pancreatic Cancer
por: Mehdorn, Anne-Sophie, et al.
Publicado: (2022)

Paracrine Interaction of Cholangiocellular Carcinoma with Cancer-Associated Fibroblasts and Schwann Cells Impact Cell Migration
por: Gundlach, Jan-Paul, et al.
Publicado: (2022)

Computer-aided transrectal ultrasound: does prostate HistoScanning™ improve detection performance of prostate cancer in repeat biopsies?
por: Hamann, Moritz Franz, et al.
Publicado: (2015)

Urine biopsy technologies: Cancer and beyond
por: Chen, Chun Kwan, et al.
Publicado: (2020)

Urine as a Source of Liquid Biopsy for Cancer
por: Oshi, Masanori, et al.
Publicado: (2021)

Laparoscopic varicocelectomy in male infertility: Improvement of seminal parameters and effects on spermatogenesis
por: Seiler, Felix, et al.
Publicado: (2021)

Application of ultrasound imaging biomarkers (HistoScanning™) improves staging reliability of prostate biopsies
por: Hamann, M. F., et al.
Publicado: (2017)

Detection of Marker Associated with CTC in Colorectal Cancer in Mononuclear Cells of Patients with Benign Inflammatory Intestinal Diseases
por: Born, Johanna, et al.
Publicado: (2021)

Preputioplasty as a surgical alternative in treatment of phimosis
por: Osmonov, Daniar, et al.
Publicado: (2021)

Breaking the crosstalk of the Cellular Tumorigenic Network by low-dose combination therapy in lung cancer patient-derived xenografts
por: Gürgen, Dennis, et al.
Publicado: (2022)

Impact of the Monocarboxylate Transporter-1 (MCT1)-Mediated Cellular Import of Lactate on Stemness Properties of Human Pancreatic Adenocarcinoma Cells †
por: Sandforth, Leontine, et al.
Publicado: (2020)

Liquid Biopsy in Gastric Cancer: Analysis of Somatic Cancer Tissue Mutations in Plasma Cell-Free DNA for Predicting Disease State and Patient Survival
por: Varkalaite, Greta, et al.
Publicado: (2021)

Urine Biopsy—Liquid Gold for Molecular Detection and Surveillance of Bladder Cancer
por: Satyal, Uttam, et al.
Publicado: (2019)

Longitudinal Analysis of Circulating Tumor Cells in Colorectal Cancer Patients by a Cytological and Molecular Approach: Feasibility and Clinical Application
por: Hendricks, Alexander, et al.
Publicado: (2021)

Isolation and Enumeration of CTC in Colorectal Cancer Patients: Introduction of a Novel Cell Imaging Approach and Comparison to Cellular and Molecular Detection Techniques
por: Hendricks, Alexander, et al.
Publicado: (2020)

Stage IV Colorectal Cancer Patients with High Risk Mutation Profiles Survived 16 Months Longer with Individualized Therapies
por: Hendricks, Alexander, et al.
Publicado: (2020)

Cytoprotection “gone astray”: Nrf2 and its role in cancer
por: Geismann, Claudia, et al.
Publicado: (2014)

Integrated RNA and metabolite profiling of urine liquid biopsies for prostate cancer biomarker discovery
por: Lee, Bongyong, et al.
Publicado: (2020)

Trans-Renal Cell-Free Tumor DNA for Urine-Based Liquid Biopsy of Cancer
por: Dermody, Sarah M., et al.
Publicado: (2022)

Urine Exosomal AMACR Is a Novel Biomarker for Prostate Cancer Detection at Initial Biopsy
por: Jin, Xin, et al.
Publicado: (2022)

Insulin Receptor in Pancreatic Cancer—Crown Witness in Cross Examination
por: Heckl, Steffen M., et al.
Publicado: (2021)

Validation of a CE-IVD, urine exosomal RNA expression assay for risk assessment of prostate cancer prior to biopsy
por: Kretschmer, Alexander, et al.
Publicado: (2022)

Identification of Urine Biomarkers to Improve Eligibility for Prostate Biopsy and Detect High-Grade Prostate Cancer
por: Alijaj, Nagjie, et al.
Publicado: (2022)

The Diversity of Liquid Biopsies and Their Potential in Breast Cancer Management
por: Keup, Corinna, et al.
Publicado: (2023)

Heat Shock Proteins in Urine as Cancer Biomarkers
por: Albakova, Zarema, et al.
Publicado: (2021)

Liquid Biopsy Biomarkers in Urine: A Route towards Molecular Diagnosis and Personalized Medicine of Bladder Cancer
por: Ferro, Matteo, et al.
Publicado: (2021)

A novel and sensitive DNA methylation marker for the urine-based liquid biopsies to detect bladder cancer
por: Deng, Leihong, et al.
Publicado: (2022)

Microbiota of Urine, Glans and Prostate Biopsies in Patients with Prostate Cancer Reveals a Dysbiosis in the Genitourinary System
por: Gonçalves, Micael F. M., et al.
Publicado: (2023)

Development of a Sensitive Digital Droplet PCR Screening Assay for the Detection of GPR126 Non-Coding Mutations in Bladder Cancer Urine Liquid Biopsies
por: Jain, Mark, et al.
Publicado: (2023)

Cancer-specific and overall survival in patients with recurrent prostate cancer who underwent salvage extended pelvic lymph node dissection
por: Osmonov, Daniar K., et al.
Publicado: (2016)

Metastatic triple-negative breast cancer patient with TP53 tumor mutation experienced 11 months progression-free survival on bortezomib monotherapy without adverse events after ending standard treatments with grade 3 adverse events
por: Meißner, Tobias, et al.
Publicado: (2017)

The liquid biopsy in lung cancer
por: Ansari, Junaid, et al.
Publicado: (2016)

Combined miRNA and SERS urine liquid biopsy for the point-of-care diagnosis and molecular stratification of bladder cancer
por: Moisoiu, Tudor, et al.
Publicado: (2022)

AKT1 and PIK3CA activating mutations in Moroccan bladder cancer patients´ biopsies and matched urine
por: El Ahanidi, Hajar, et al.
Publicado: (2022)

Transbronchial catheter aspiration compared to forceps biopsy in the diagnosis of peripheral lung cancer
por: Franke, K-J, et al.
Publicado: (2009)

Predictive biomarkers in gastric cancer
por: Röcken, C.
Publicado: (2022)

Vy-PER: eliminating false positive detection of virus integration events in next generation sequencing data
por: Forster, Michael, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_uvebgmdl84iuir46ulfgdg8gob